Ucello Therapeutics rallies $25m Series A
Ucello Therapeutics, a developer of CAR-T therapies, has closed $25 million in Series A financing.
Ucello Therapeutics, a developer of CAR-T therapies, has closed $25 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination